Yufei Xiang

2.2k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Yufei Xiang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Yufei Xiang has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Infectious Diseases. Recurrent topics in Yufei Xiang's work include Monoclonal and Polyclonal Antibodies Research (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Yufei Xiang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Yufei Xiang collaborates with scholars based in United States, China and Israel. Yufei Xiang's co-authors include Yi Shi, Zhe Sang, Dina Schneidman‐Duhovny, W. Paul Duprex, Sham Nambulli, Cheng Zhang, Bruce C. Byrne, Zhengyun Xiao, William K. Holloman and Eric B. Kmiec and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yufei Xiang

27 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

2020 265 citations Yufei Xiang, Sham Nambulli et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yufei Xiang United States	15	815	397	383	130	129	28	1.3k
Frederico Aires‐da‐Silva Portugal	18	543 0.7×	114 0.3×	268 0.7×	59 0.5×	89 0.7×	41	1.1k
Mohamed El Khattabi Netherlands	17	629 0.8×	75 0.2×	264 0.7×	91 0.7×	135 1.0×	27	1.0k
Mehdi Arbabi‐Ghahroudi Canada	19	792 1.0×	156 0.4×	831 2.2×	162 1.2×	100 0.8×	31	1.3k
Tomoko Hirama Canada	24	1.2k 1.4×	121 0.3×	742 1.9×	147 1.1×	123 1.0×	34	1.7k
Gabriela Canziani United States	21	626 0.8×	207 0.5×	458 1.2×	39 0.3×	58 0.4×	42	1.3k
Ryo Morishita Japan	17	1.2k 1.5×	83 0.2×	178 0.5×	86 0.7×	103 0.8×	39	1.6k
Ketil Winther Pedersen Norway	15	615 0.8×	455 1.1×	97 0.3×	71 0.5×	273 2.1×	17	1.4k
Zoltán Konthur Germany	22	1.1k 1.3×	64 0.2×	394 1.0×	143 1.1×	88 0.7×	49	1.5k
Theo Verrips Netherlands	28	1.1k 1.3×	237 0.6×	1.1k 2.8×	165 1.3×	77 0.6×	47	1.9k
Gianluca Veggiani Canada	13	802 1.0×	133 0.3×	299 0.8×	73 0.6×	37 0.3×	34	1.0k

Countries citing papers authored by Yufei Xiang

Since Specialization

Citations

This map shows the geographic impact of Yufei Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Xiang more than expected).

Fields of papers citing papers by Yufei Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Xiang. The network helps show where Yufei Xiang may publish in the future.

Co-authorship network of co-authors of Yufei Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufei Xiang. A scholar is included among the top collaborators of Yufei Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufei Xiang. Yufei Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Zhijie, Li Chen, Jing Liu, et al.. (2024). The First‐In‐Class Deubiquitinase‐Targeting Chimera Stabilizes and Activates cGAS. Angewandte Chemie International Edition. 64(3). e202415168–e202415168. 12 indexed citations

Yang, Zhijuan, et al.. (2024). Molecular characterization of a novel mycotombus‑like virus isolated from the phytopathogenic fungus Nigrospora oryzae. Archives of Virology. 169(11). 224–224. 1 indexed citations

Zhao, Haiyan, Yufei Xiang, Sohail Malik, et al.. (2024). An IDR-dependent mechanism for nuclear receptor control of Mediator interaction with RNA polymerase II. Molecular Cell. 84(14). 2648–2664.e10. 3 indexed citations

Xiang, Yufei, et al.. (2024). Structural insights into RNA cleavage by a novel family of bacterial RNases. Nucleic Acids Research. 52(17). 10705–10716. 1 indexed citations

Xiang, Yufei, Jialu Xu, Briana L McGovern, et al.. (2024). Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy. Cell. 187(24). 6966–6980.e23. 11 indexed citations

Sang, Zhe, et al.. (2023). Nanobodies: Robust miniprotein binders in biomedicine. Advanced Drug Delivery Reviews. 195. 114726–114726. 38 indexed citations

Lu, Manman, Dmitri Toptygin, Yufei Xiang, et al.. (2022). The Magic of Linking Rings: Discovery of a Unique Photoinduced Fluorescent Protein Crosslink. Journal of the American Chemical Society. 144(24). 10809–10816. 7 indexed citations

Yang, Haibo, Yumin Wang, Yufei Xiang, et al.. (2022). FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. Proceedings of the National Academy of Sciences. 119(12). e2116251119–e2116251119. 102 indexed citations

Cheng, Mary Hongying, James Krieger, Anupam Banerjee, et al.. (2022). Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions. iScience. 25(3). 103939–103939. 34 indexed citations

10.

Tubiana, Jérôme, Yufei Xiang, Li Fan, et al.. (2022). Reduced B cell antigenicity of Omicron lowers host serologic response. Cell Reports. 41(3). 111512–111512. 12 indexed citations

11.

Xiang, Yufei, Wei Huang, Hejun Liu, et al.. (2022). Superimmunity by pan-sarbecovirus nanobodies. Cell Reports. 39(13). 111004–111004. 22 indexed citations

12.

Nambulli, Sham, Yufei Xiang, Natasha L. Tilston‐Lunel, et al.. (2021). Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Science Advances. 7(22). 107 indexed citations

13.

Cheng, Mary Hongying, James Krieger, Yufei Xiang, et al.. (2021). Impact of New Variants on SAR-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions. SSRN Electronic Journal. 2 indexed citations

14.

Sang, Zhe, Yufei Xiang, İvet Bahar, & Yi Shi. (2021). Llamanade: An open-source computational pipeline for robust nanobody humanization. Structure. 30(3). 418–429.e3. 34 indexed citations

15.

Sun, Dapeng, Zhe Sang, Yong Joon Kim, et al.. (2021). Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes. Nature Communications. 12(1). 4676–4676. 66 indexed citations

16.

Xiang, Yufei, Zhe Sang, Jianquan Xu, et al.. (2021). Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies. Cell Systems. 12(3). 220–234.e9. 36 indexed citations

17.

Zhu, Xiaolan, Xiangyu Wang, Wei Yan, et al.. (2021). Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response. NAR Cancer. 3(1). zcab010–zcab010. 12 indexed citations

18.

Xiang, Yufei, Sham Nambulli, Zhengyun Xiao, et al.. (2020). Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science. 370(6523). 1479–1484. 265 indexed citations breakdown →

19.

Teng, Yaqun, Tribhuwan Yadav, Mei-Han Duan, et al.. (2018). ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSB. Nature Communications. 9(1). 4115–4115. 132 indexed citations

20.

Fang, Gang, et al.. (2011). Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 22(45). 455102–455102. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact